Aug 15, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Veru Announces Novel Modified-Release Oral Formulation for Enobosarm
VERU unveils a novel modified-release oral enobosarm to enhance fat loss while preserving lean mass in chronic weight loss management.
Aug 07, 2025 • Benzinga
SOMEWHAT-BULLISH
Here's How Much You Would Have Made Owning Scholar Rock Holding Stock In The Last 5 Years - Scholar Rock Holding ( NASDAQ:SRRK )
Scholar Rock Holding SRRK has outperformed the market over the past 5 years by 7.22% on an annualized basis producing an average annual return of 21.06%. Currently, Scholar Rock Holding has a market capitalization of $3.16 billion.
Aug 06, 2025 • Motley Fool
NEUTRAL
Why Scholar Rock Stock Wilted on Wednesday
The market was hoping the company could better contain its losses.
Aug 06, 2025 • Motley Fool
NEUTRAL
Scholar Rock ( SRRK ) Q2 Loss Widens 63%
Scholar Rock ( NASDAQ:SRRK ) , a late-stage biopharmaceutical company specializing in therapies for serious neuromuscular and rare diseases, released its second quarter 2025 earnings on August 6, 2025. The key news was continued preparation for the potential 2025 U.S. launch of apitegromab, its ...
Jul 23, 2025 • Motley Fool
SOMEWHAT-BULLISH
Director Sells 11,136 Shares of SRRK, a Stock Up 330% in Past Year
On July 18, 2025, Director Jeffrey S. Flier disclosed the sale of 11,136 shares of Scholar Rock ( NASDAQ:SRRK ) in an open market transaction.Source: SEC Form 4 filing from July 18. The insider transaction occurred on July 16.How does the transaction compare to previous insider activity?This is ...
Jul 08, 2025 • Benzinga
SOMEWHAT-BULLISH
Agios Appoints Dr. Jay Backstrom to Board of Directors - Agios Pharmaceuticals ( NASDAQ:AGIO )
CAMBRIDGE, Mass., July 08, 2025 ( GLOBE NEWSWIRE ) -- Agios Pharmaceuticals, Inc. AGIO, a leader in cellular metabolism and pyruvate kinase ( PK ) activation pioneering therapies for rare diseases, today announced the appointment of Jay Backstrom, M.D., M.P.H., to its Board of Directors, ...